Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Conference topics

Home » Conference topics
  • 2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated,  Bone Modifying Therapy, Molecular Diagnosis

    2023.10.24
  • WCLC 2023 : Dr. Wu Yilong, Dr. Cheng Ying, and Dr.Han Baohui Discuss the latest advancements in Small Cell Lung Cancer Research and Analyze the Development of ADC

    2023.10.23
  • WCLC 2023 | Dr. Liu: Immunotherapy Combined Chemotherapy Can Bring Long-term Survival Benefits to ES-SCLC Patients

    2023.10.23
  • WCLC 2023 | Dr. Chen Haiquan: The Asian Perspective on Lung Cancer Screening

    2023.10.23
  • WCLC 2023 | Dr. Han Baohui’s Team Presents Multiple Research Achievements, Making China’s Voice Resonate at WCLC

    2023.10.23
  • WCLC 2023 | Dr. Shi Meiqi: Treatment Strategies for EGFR Mutation and KRAS Mutation Non-Small Cell Lung Cancer

    2023.10.23
  • WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer

    2023.10.23
  • WCLC Voice of China | Dr. Xie Huikang: The Value of Lepidic and Invasion Patterns New Diagnostic Criteriafor the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma

    2023.10.23
  • WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months

    2023.10.23
«previous next»
Recent Posts
  • Professor Dingwei Ye: Building an Authoritative Academic Platform in Uro-Oncology and Driving Continuous Progress in Urothelial Carcinoma Management |
  • Professor Hao Zeng’s Team Publishes in JAMA Oncology: Innovative First-Line Immunotherapy Approach for Advanced FH-Deficient Renal Cell Carcinoma
  • AI-Driven Imaging Breakthrough in CAR-T Therapy丨Professor Stephen Schuster on Predicting Efficacy
  • Polatuzumab Improves Survival in Relapsed/Refractory DLBCL丨Phase III POLARGO Study Highlights
  • Breakthrough Discovery of LymphoMAPs in Large B-cell Lymphoma丨Professor David Russler-Germain on CAR T Therapy
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top